stella
beta
Real World Efficiency of Abrocitinib Treatment at Patients With Moderate to Severe Atopic Dermatitis Who Had Inadequate Response to Previous Biologic Therapies. — Stella
Recruiting
Back to Atopic Dermatitis trials
Trial locations
(1 site)
United States
Pfizer, New York, New York
View full record on ClinicalTrials.gov